Regulation of Erk1/2 activation by osteopontin in PC3 human prostate cancer cells
Brian W. Robertson(University of Maryland, Baltimore), Meenakshi A. Chellaiah(University of Maryland, Baltimore)
Cited by 65
Related Papers
Integrin αvβ3 and CD44 pathways in metastatic prostate cancer cells support osteoclastogenesis via a Runx2/Smad 5/receptor activator of NF-κB ligand signaling axis
|Molecular Cancer|2012|76
C-phycocyanin attenuates RANKL-induced osteoclastogenesis and bone resorption in vitro through inhibiting ROS levels, NFATc1 and NF-κB activation
|Scientific Reports|2020|46
Characterization of CD44 intracellular domain interaction with RUNX2 in PC3 human prostate cancer cells
|Cell Communication and Signaling|2019|44
Promising Noninvasive Cellular Phenotype in Prostate Cancer Cells Knockdown of Matrix Metalloproteinase 9
|The Scientific World JOURNAL|2013|34
Androgen receptor expression reduces stemness characteristics of prostate cancer cells (PC3) by repression of CD44 and SOX2
|Journal of Cellular Biochemistry|2018|31